Early invasive treatment benefits patients with renal dysfunction in unstable coronary artery disease

American Heart Journal

Volumn 152, Issue 6, 2006, Pages 1052-1058

  Johnston, Nina ^a   Jernberg, Tomas ^b   Lagerqvist, Bo ^a   Wallentin, Lars ^b  

^a Department of Medical Sciences   (Sweden)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIDIABETIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CREATININE; DALTEPARIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

AGED; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; CLINICAL TRIAL; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CREATININE CLEARANCE; DEATH; EARLY INTERVENTION; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; INTERMETHOD COMPARISON; KIDNEY DISEASE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; STATISTICAL ANALYSIS;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; COHORT STUDIES; CORONARY ARTERIOSCLEROSIS; CORONARY ARTERY BYPASS; CREATININE; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY DISEASES; MALE; MIDDLE AGED; MULTICENTER STUDIES; MYOCARDIAL INFARCTION; RANDOMIZED CONTROLLED TRIALS; TIME FACTORS;

EID: 33845242750     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2006.07.014     Document Type: Article

References (19)

1. Januzzi J.L., Cannon C.P., DiBattiste P.M., et al. Effects of renal insufficiency on early invasive management in patients with acute coronary syndromes (the TACTICS-TIMI 18 trial). Am J Cardiol 90 (2002) 1246-1249
2. James S., Lindahl B., Siegbahn A., et al. N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a Global Utilization of Strategies to Open occluded arteries (GUSTO)-IV substudy. Circulation 108 (2003) 275-281
3. Jernberg T., Lindahl B., James S., et al. Cystatin C: a novel predictor of outcome in suspected or confirmed non-ST-elevation acute coronary syndrome. Circulation 110 (2004) 2342-2348
4. Bertrand M.E., Simoons M.L., Fox K.A., et al. Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J 23 (2002) 1809-1840
5. Kahn J.K., Rutherford B.D., McConahay D.R., et al. Short- and long-term outcome of percutaneous transluminal angioplasty in chronic dialysis patients. Am Heart J 119 (1990) 484-489
6. Reusser L.M., Osborn L.A., White H.J., et al. Increased morbidity after coronary angioplasty in patients on chronic hemodialysis. Am J Cardiol 73 (1994) 965-967
7. Ahmed W.H., Shubrooks S.J., Gibson C.M., et al. Complications and long-term outcome after percutaneous coronary angioplasty in chronic hemodialysis patients. Am Heart J 128 (1994) 252-255
8. Schoebel F.C., Gradaus F., Ivens K., et al. Restenosis after elective coronary angioplasty in patients with end-stage renal disease: a case control study using quantitative coronary angiography. Heart 78 (1997) 337-342
9. Morcos S.K., Thomsen H.S., and Webb J.A. Contrast media induced nephrotoxicity: a consensus report. Eur Radiol 9 (1999) 1602-1613
10. Keeley E.C., Kadakia R., Soman S., et al. Analysis of long-term survival after revascularization in patients with chronic kidney disease presenting with acute coronary syndromes. Am J Cardiol 92 (2003) 509-514
11. FRISC-2 Investigators. Invasive compared with non-invasive treatment in unstable coronary artery disease: FRISC II prospective randomised multicentre study. Lancet 354 (1999) 708-715
12. Wallentin L. Non-ST-elevation acute coronary syndrome: fuel for the invasive strategy. Lancet 360 (2002) 738-739
13. Lagerqvist B., Husted S., Konty F., et al. A long-term perspective on the protective effects of an early invasive strategy in unstable coronary artery disease: two-year follow-up of the FRISC-II invasive study. J Am Coll Cardiol 40 (2002) 1902-1914
14. Cockroft D., and Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron 16 (1976) 31-41
15. Morrow D.A., and Braunwald E. Future of biomarkers in acute coronary syndromes: moving toward a multimarker strategy. Circulation 108 (2003) 250-252
16. McCullough P.A., Soman S.S., Shah S.S., et al. Risks associated with renal dysfunction in patients in the coronary care unit. J Am Coll Cardiol 36 (2000) 679-684
17. Santopinto J.J., Fox K.A., Goldberg R.J., et al. Creatinine clearance and adverse hospital outcomes in patients with acute coronary syndromes: findings from the Global Registry of Acute Coronary Events (GRACE). Heart 89 (2003) 1003-1008
18. Lameire N., Jager K., Van Biesen W., et al. Chronic kidney disease: a European perspective. Kidney Int Suppl 99 (2005) S30-S38
19. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39 2 suppl 1 (2002) S1-S266